This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Han Wha Pharma Co., Ltd., Yang Ji Chemical Co., Ltd.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 3 
1 out of 4 Years Active: 2018
Title: Kyeoung Ah Kim: Innovator in Janus Kinase Inhibition
Introduction
Kyeoung Ah Kim is a notable inventor based in Anseong-si, South Korea. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds that serve as inhibitors for specific biological targets.
Latest Patents
Kyeoung Ah Kim holds a patent for a compound titled "Substituted N-(pyrrolidine-3-yl)-7H-pyrrolo[2,3-D]pyrimidine-4-amine." This innovative compound is recognized for its potential use as a Janus kinase (JAK) inhibitor. The patent outlines the unique structure of the compound and its applications in therapeutic settings.
Career Highlights
Throughout his career, Kyeoung Ah Kim has worked with reputable companies such as Yang Ji Chemical Co., Ltd. and Han Wha Pharma Co., Ltd. His experience in these organizations has allowed him to refine his skills in drug development and innovation.
Collaborations
Kyeoung Ah Kim has collaborated with several professionals in his field, including Jong Min Kim and Chie Yeon Chough. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Kyeoung Ah Kim is a distinguished inventor whose work in Janus kinase inhibition showcases his expertise and dedication to advancing medicinal chemistry. His contributions are valuable to the scientific community and hold promise for future therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile